Optimization of paclitaxel containing pH-sensitive liposomes by 3 factor, 3 level box-behnken design

Indian Journal of Pharmaceutical Sciences

Volumn 75, Issue 4, 2013, Pages 420-426

  Rane, Smita ^a   Prabhakar, Bala ^b  

^a School of Pharmacy and Technology Management   (India)

^b SVKM s Narsee Monjee Institute of Management Studies   (India)

Author keywords

Box Behnken design; liposomes; optimization; paclitaxel; pH sensitive

Indexed keywords

CHOLESTERYLHEMISUCCINIC ACID; DIOLYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; PACLITAXEL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPENDENT VARIABLE; DRUG DESIGN; FILM; HYDRATION; IN VITRO STUDY; INDEPENDENT VARIABLE; LIPOSOMAL DELIVERY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PARTICLE SIZE; PH; PROCESS OPTIMIZATION;

EID: 84886392673     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.119820     Document Type: Article

References (19)

1. Appendino G. Taxol® (Paclitaxel): Historical and Ecological aspects. Fitoterapia 1993;45:5-27.
2. Chervinsky DS, Brecher ML, Hoelcle MJ. Cremophor EL enhances taxol efficacy in a multidrug resistant C1300 nuroblastoma cell line. Anticancer Res 1993;13:93-6. (Pubitemid 23118201)
3. Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D. Measurement of cremophor EL following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug resistant phenotype. J Natl Cancer Inst 1993;85:1685-90. (Pubitemid 23315427)
4. Fjallskog ML, Frii L, Bergh J. Is cremophor, solvent for paclitaxel, cytotoxic Lancet 1993;342:873.
5. Rowinsky EK, Eisenhauer EA, Chaudry V, Arbuck SG, Donehower RC, Bishop J, et al. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993;20:1-15. (Pubitemid 23239390)
6. Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother 1994;28:S11-4. (Pubitemid 24139914)
7. Goldspiel BR. Pharmaceutical issues: Preparation, administration, stability, and compatibility with other medications. Ann Pharmacother 1994;28:S23-6. (Pubitemid 24139917)
8. Karanth H, Murthy RS. pH-sensitive liposomes-principle and application in cancer therapy. J Pharm Pharmacol 2007;59:469-83. (Pubitemid 47051120)
9. Lewis GA, Mathieu D, Phan-Tan-Luu R. Pharmaceutical Experimental Design. New York: Marcel Dekker; 1999.
10. Sanchez-Lafuente C, Furlanetto S, Fernandez-Arevalo M, Alvarez-Fuentes J, Rabasco AM, Faucci MT, et al. Didanosine extended-release matrix tablets: Optimization of formulation variables using statistical experimental design. Int J Pharm 2002;237:107-18. (Pubitemid 34310484)
11. Mura P, Furlanetto S, Cirri M, Maestrelli F, Marras AM, Pinzauti S. Optimization of glybenclamide tablet composition through the combined use of Differential Scanning Calorimetry and D-optimal mixture design. J Pharm Biomed Anal 2005;37:65-71. (Pubitemid 40138717)
12. Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release 1998;51:115-22. (Pubitemid 28252862)
13. Nazzal S, Khan MA. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS PharmSciTech 2002;3:23-31.
14. Li S, Lin S, Chien YW, Daggy BP, Mirchandani HL. Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS PharmSciTech 2001;2:11-22.
15. Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3 level Box-Behnken Design. AAPS PharmSciTech 2007;8:43-9.
16. Box GE, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455-75.
17. Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel containing liposomes. J Control Release 2000;63:19-30. (Pubitemid 30046939)
18. Dosio F, Brusa P, Crosasso P, Arpicco S, Cattel L. Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate. J Control Release 1997;47:293-304. (Pubitemid 27220212)
19. Sharma A, Conway WD, Straubinger RM. Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma. J Chromatogr B Biomed Appl 1994;655:315-9. (Pubitemid 24169268)